Online Makale
Online Hizmetlere Toplu BakışHaydarpasa Numune Egitim ve Arastirma Hastanesi Tip Dergisi
Haydarpasa Numune Med J. 2024; 64(1): 12-17 | DOI: 10.14744/hnhj.2022.46353 | |||
Management of Immunosuppression Treatment in Autoimmune Liver Disease and Liver Transplantation Patients Infected with COVID-19Şevki Konur1, Ismet Kızılkaya1, Ergin Turgut1, Güner Kılıç2, Ramazan Dertli2, Yusuf Kayar21Department of Internal Medicine, Van Training and Research Hospital, Van, Turkiye2Department of Internal Medicine, Division of Gastroenterology, Van Training and Research Hospital, Van, Turkiye INTRODUCTION: It is known that viral infections progress more seriously in immunosuppressed patients than in the healthy population. In the literature, there is limited information on the course of COVID-19 infection in patients with autoimmune liver disease (AID) who receive immunosuppressive therapy, and in patients who have undergone liver transplantation. We present in detail the course of twelve patients, including six patients with AID and six patients with liver transplantation, who had COVID-19 infection and were followed up under immunosuppressive therapy. Şevki Konur, Ismet Kızılkaya, Ergin Turgut, Güner Kılıç, Ramazan Dertli, Yusuf Kayar. Management of Immunosuppression Treatment in Autoimmune Liver Disease and Liver Transplantation Patients Infected with COVID-19. Haydarpasa Numune Med J. 2024; 64(1): 12-17 Sorumlu Yazar: Yusuf Kayar, Türkiye |
|